Interesting results of catalytic hydrogenation of 3-(2-nitrophenyl) isoxazoles and 3- (nitrophenyl)-4,5-dihydroisoxazoles

Synthesis

Volumn , Issue 12, 2006, Pages 1995-2004

  Singh, V ^a   Madapa, S ^a   Yadav, G P ^a   Maulik, P R ^a   Batra, S ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

4 aminoqukioline; Hydrogenation; Isoxazole; Regiospecific; Ring transformation

Indexed keywords

CATALYSIS; HYDROGENATION; REDUCTION; SUBSTITUTION REACTIONS;

4-AMINOQUKIOLINE; ISOXAZOLE; REGIOSPECIFIC; RING TRANSFORMATION;

ORGANIC COMPOUNDS;

3 (2 NITROPHENYL)ISOXAZOLE DERIVATIVE; 3 (NITROPHENYL) 4,5 DIHYDROISOXAZOLE DERIVATIVE; 4 AMINOQUINOLINE DERIVATIVE; ISOXAZOLE DERIVATIVE; NITRO DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; CHEMICAL STRUCTURE; CRYSTAL STRUCTURE; HYDROGENATION; HYDROGENOLYSIS; PHYSICAL PARAMETERS; RING CLOSING METATHESIS;

EID: 33745759188     PISSN: 00397881     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-942388     Document Type: Article

References (36)

1. th January, 2006.
2. (a) Godard, A.; Queguiner, G. J. Heterocycl. Chem. 1980, 17, 465.
3. (b) Veronese, A. C.; Callegari, S. A.; Salah, S. A. A. Tetrahedron Lett. 1990, 31, 3485.
4. Thomsen, I.; Torssel, K. B. G. Acta Chem. Scand. B 1988, 42, 309.
5. Jensen, S.; Torssel, K. B. G. Acta Chem. Scand. B 1995, 19, 53.
6. (a) Reuben, B. G.; Wittcoff, H. A. Pharmaceutical Chemicals in Perspective; Wiley: New York, 1989.
7. (b) McIntosh, H. M.; Greenwood, B. M. Ann. Trop. Med. Parasitol. 1998, 92, 265.
8. (c) Deshpande, S. S.; Sheridan, R. E.; Adler, M. Toxicon 1997, 35, 433.
9. (d) Slater, A. F. Pharmacol. Ther. 1993, 57, 203.
10. (e) O'Neill, P. M.; Willock, D. J.; Hawley, S. R.; Bray, P. G.; Storr, R. C.; Ward, S. A.; Park, B. K. J. Med. Chem. 1997, 40, 437; and references therein.
11. (f) Madrid, P. B.; Sherrill, J.; Liou, A. P.; Weisman, J. L.; DeRisi, J. L.; Guy, R. K. Bioorg. Med. Chem. Lett. 2005, 15, 1015.
12. (a) Andrews, I. P.; Bannister, R.; Etridge, S. K.; Lewis, N. J.; Mullane, M. V.; Wells, A. S. Tetrahedron Lett. 1995, 36, 7743.
13. (b) Ife, R. F.; Brown, T. H.; Keeling, D. J.; Leach, C. A.; Meeson, M. L.; Persons, M. E.; Reavill, D. R.; Theobald, C. J.; Wiggall, K. J. J. Med. Chem. 1992, 35, 3413.
14. Moyer, M. P.; Weber, F. H.; Gross, J. L.; Isaac, J. W.; Saint Fort, R. Bioorg. Med. Chem. Lett. 1992, 2, 1589.
15. Kireev, D. B.; Chretien, J. R.; Raevsky, D. A. Eur. J. Med. Chem. 1995, 30, 395.
16. (a) Marco, J. L.; Carreiras, M. C. Mini Rev. Med. Chem. 2003, 3, 518.
17. (b) Doucet-Personeni, C.; Bentley, P. D.; Fletcher, R. J.; Kinkaid, A.; Kryger, G.; Pirard, B.; Taylor, A.; Taylor, R.; Taylor, J.; Viner, R.; Silman, I.; Sussman, J. L.; Greenblatt, H. M.; Lewis, T. J. Med. Chem. 2001, 44, 3203.
18. (c) Han, Y. F.; Li, C. P.; Chow, E.; Wang, H.; Pang, Y. P.; Carlier, P. R. Bioorg. Med. Chem. 1999, 7, 2569.
19. Shinkai, H.; Ito, T.; Iida, T.; Kitao, Y.; Yamada, H.; Uchida, I. J. Med. Chem. 2000, 43, 4667.
20. Medebielle, M.; Hohn, S.; Okada, E.; Myoken, H.; Shibata, D. Tetrahedron Lett. 2005, 46, 7817.
21. Roy, A. K.; Batra, S. Synthesis 2003, 1347.
22. Balsamo, A.; Coletta, I.; Guglielmotti, A.; Landolfi, C.; Mancini, F.; Martinelli, A.; Milanese, C.; Minutolo, F.; Nencetti, S.; Orlandini, E.; Pinza, M.; Rapposelli, S.; Rosello, A. Eur. J. Med. Chem. 2003, 38, 157.
23. (a) Saxena, R.; Singh, V.; Batra, S. Tetrahedron 2004, 60, 10311.
24. (b) Singh, V.; Saxena, R.; Batra, S. J. Org. Chem. 2005, 70, 353.
25. (c) Roy, A. K.; Pathak, R.; Yadav, G. P.; Maulik, P. R.; Batra, S. Synthesis 2006, in press.
26. Purwono, B.; Smalley, R. K.; Porter, T. C. Synlett 1992, 231.
27. (a) Kozikowski, A. P.; Stein, P. D. J. Am. Chem. Soc. 1982, 104, 4023.
28. (b) Curran, D. P. J. Am. Chem. Soc. 1982, 104, 4024.
29. (c) Curran, D. P. J. Am. Chem. Soc. 1983, 105, 4024.
30. (d) Auricchio, S.; Ricca, A. Tetrahedron 1987, 43, 3983.
31. Quan, M. L.; Ellis, C. D.; He, M. Y.; Liauw, A. Y.; Lam, P. Y. S.; Rossi, K. A.; Knabb, R. M.; Luettgen, J. M.; Wright, M. R.; Wong, P. C.; Wexler, R. R. Bioorg. Med. Chem. Lett. 2003, 13, 1023.
32. Vittorio, F.; Ronsisvalle, G.; Pappalardo, M. S.; Blandino, G. Farmaco 1985, 40, 359.
33. 2. Programs: XSCANS [Siemens Analytical X-ray Instrument Inc.: Madison, WI, USA, 1996) was used for data collection and data processing], SHELXTL-NT [(Bruker Axs Inc.: Madison, Wisconsin, USA 1997) was used for structure determination, refinements and molecular graphics]. Further details of the crystal structure investigation can be obtained from the Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge, CB2 1EZ, UK (CCDC deposition no. of compound 7d: 297540.
34. (a) Patra, A.; Batra, S.; Kundu, B.; Joshi, B. S.; Roy, R.; Bhaduri, A. P. Synthesis 2001, 276.
35. (b) Batra, S.; Roy, A. K.; Patra, A.; Bhaduri, A. P.; Surin, W. S.; Raghvan, S. A. V.; Sharma, P.; Kapoor, K.; Dikshit, M. Bioorg. Med. Chem. 2004, 12, 2059.
36. Srivastava, S.; Bajpai, L. K.; Batra, S.; Bhaduri, A. P.; Maikuri, J. P.; Gupta, G.; Dhar, J. D. Bioorg, Med. Chem. 1999, 7, 2607.